NATALIE trial - Ribociclib - Tiny IDFS and imbalanced censoring | Why the trial is flawed
Vinay Prasad MD MPH Vinay Prasad MD MPH
187K subscribers
4,837 views
178

 Published On Apr 11, 2024

Vinay Prasad, MD MPH; Physician & Professor
Hematologist/ Oncologist
Professor of Epidemiology, Biostatistics and Medicine
Author of 450+ Peer Reviewed papers, 2 Books, 2 Podcasts, 100+ op-eds.
If you want to contact me, do it here: http://www.vinayakkprasad.com/contact

Google Scholar: https://scholar.google.com/citations?...
Substack: https://vinayprasadmdmph.substack.com/
Podcast: https://podcasts.apple.com/us/podcast...
Personal Website: www.vinayakkprasad.com
Laboratory Website: www.vkprasadlab.com
Podcast Website: www.plenarysessionpodcast.com
Academic Publications: http://www.vinayakkprasad.com/papers


Follow me on:
Twitter @vprasadmdmph

show more

Share/Embed